In Section A, contributors will receive unique doses and schedules of oral ABBV-744 pill to determine Secure dosing routine. Further contributors will probably be enrolled for the identified monotherapy dosign regimen. In Segment B, individuals will get oral ruxolitinib and ABBV-744 might be specified as "include-on" therapy. In Segment C, https://connersdnxi.blogripley.com/32560920/considerations-to-know-about-abbv-744-brd4-inhibitor-cancer-therapy-efficacy